Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 644 (ZNF644) is a multi-zinc finger transcription factor that plays a role in the regulation of gene expression by binding specific DNA sequences and targeting regulatory protein complexes to chromatin[1][5][3]. ZNF644 is a core subunit of the G9a/GLP histone methyltransferase complex, participating in the targeting of this complex to specific gene loci for histone H3 lysine 9 (H3K9) methylation and transcriptional repression[1]. Mutations in ZNF644 have been associated with sporadic cases of high myopia in humans[5][3]. The protein contains multiple zinc finger motifs, enabling sequence-specific binding to DNA and facilitating its function in chromatin remodeling and repression of gene transcription[1][5][3]. There are currently no known approved drugs that directly target ZNF644, and it has not been established as a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 644 (ZNF644).